Immunohistochemical Assessment of DCBLD2 and PDZD3 Expression in Pancreatic Ductal Adenocarcinoma

被引：0
作者：
Gopal, P.
Cornish, T. C.
Merchant, N. B.
Hruban, R. H.
Shi, C.
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Johns Hopkins Univ, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1529
引用
收藏
页码：360A / 361A
页数：2
相关论文
共 50 条
  • [41] Gene expression profiles of microdissected pancreatic ductal adenocarcinoma
    Grützmann, R
    Foerder, M
    Alldinger, I
    Staub, E
    Brümmendorf, T
    Röpcke, S
    Li, XZ
    Kristiansen, G
    Jesnowski, R
    Sipos, B
    Löhr, M
    Lüttges, J
    Ockert, D
    Klöppel, G
    Saeger, HD
    Pilarsky, C
    VIRCHOWS ARCHIV, 2003, 443 (04) : 508 - 517
  • [42] Cyclin E expression and outcome in pancreatic ductal adenocarcinoma
    Skalicky, David A.
    Kench, James G.
    Segara, Davendra
    Coleman, Maxwell J.
    Sutherland, Robert L.
    Henshall, Susan M.
    Musgrove, Elizabeth A.
    Biankin, Andrew V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1941 - 1947
  • [43] Expression of c-erbB-2 and cyclooxygenase-2 in pancreatic ductal adenocarcinoma
    Choi, Hye Jeong
    Kim, Hong Jin
    Yun, Sung Soo
    Choi, Joon Hyuck
    KOREAN JOURNAL OF PATHOLOGY, 2007, 41 (03) : 171 - 175
  • [44] mRNA expression of PSCA and ERBB2 in pancreatic ductal adenocarcinoma.
    Ma, Hong
    Huang, Shuguang
    Becerra, Carlos
    Moseley, Annemarie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma
    Zheng, Jiawei
    Huang, Shanshan
    Huang, Yufang
    Song, Li
    Yin, Yin
    Kong, Wencui
    Chen, Xiong
    Ouyang, Xuenong
    TUMOR BIOLOGY, 2016, 37 (06) : 7853 - 7859
  • [46] Reevaluation and Identification of the Best Immunohistochemical Panel for Differentiating Breast Ductal Adenocarcinoma from Pancreatic Adenocarcinoma
    Liu, H.
    Shi, J.
    Prichard, J. W.
    Lin, F.
    MODERN PATHOLOGY, 2010, 23 : 59A - 59A
  • [47] Reevaluation and Identification of the Best Immunohistochemical Panel for Differentiating Breast Ductal Adenocarcinoma from Pancreatic Adenocarcinoma
    Liu, H.
    Shi, J.
    Prichard, J. W.
    Lin, F.
    LABORATORY INVESTIGATION, 2010, 90 : 59A - 59A
  • [48] MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma
    Chen, Da-Wei
    Fan, Yao-Fu
    Li, Jiang
    Jiang, Xiao-Xiao
    TUMOR BIOLOGY, 2013, 34 (03) : 1553 - 1557
  • [49] INCREASED MDM2 EXPRESSION AND IMMUNOREACTIVITY IN HUMAN PANCREATIC DUCTAL ADENOCARCINOMA
    EBERT, M
    YOKOYAMA, M
    KOBRIN, MS
    FRIESS, H
    BUCHLER, MW
    KORC, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (06) : 1279 - 1284
  • [50] Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma
    Qiu, Zhaoyan
    Chu, Yi
    Xu, Bing
    Wang, Qian
    Jiang, Mingzuo
    Li, Xiaowei
    Wang, Gang
    Yu, Pengfei
    Liu, Guoxiao
    Wang, Hua
    Kang, Huijie
    Liu, Jiayu
    Zhang, Yu
    Jin, Jian-Ping
    Wu, Kaichun
    Liang, Jie
    ONCOTARGET, 2017, 8 (34) : 56428 - 56442
12345